TREXIMET (Formerly Known as TREXIMA) for the Acute Treatment of Probable Migraine (ICHD-II 1.6.1)

Clinical trial NCT00387881 · COMPLETED

Trial details

NCT number: NCT00387881
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine, Without Aura

Start date: 2006-09-01
Primary completion: 2008-02-01
Enrollment: 679

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.